Cartesian Therapeutics
RNAC
#7439
Rank
HK$2.49 B
Marketcap
HK$94.71
Share price
3.21%
Change (1 day)
-45.01%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -HK$2.51

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$2.48. In 2021 the company made an earnings per share (EPS) of -HK$1.86 an increase over its 2020 EPS that were of -HK$5.35.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$2.51
2021-HK$1.86-65.22%
2020-HK$5.35-43.44%
2019-HK$9.46-58.08%
2018-HK$22.57-9.35%
2017-HK$24.90-29.16%
2016-HK$35.15